arzerra
Arzerra 100 mg Injection is an anticancer medication used to treat chronic lymphocytic leukemia a type of blood and bone marrow cancer It is used alone or in combination with other drugs when patients have not responded well to fludarabine and alemtuzumab treatment Arzerra is administered by a doctor through intravenous injection The dosage and frequency of Arzerra injections will be determined by your doctor based on your specific condition It is important to follow your doctors instructions and not exceed the prescribed dosage Taking Arzerra incorrectly or in excess can lead to severe side effects While the benefits of this medication may take some time to be noticeable it is crucial not to discontinue the treatment without your doctors guidance Please note that Arzerra is not recommended for individuals under the age of 18

More medicines by Glaxo SmithKline Pharmaceuticals Ltd
Available in 2 variations

vial of 3 injections

Arzerra 1000mg Solution for infusion
vial of 50 ml Solution for infusion
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
arzerra
Prescription Required
Manufacturer :
Glaxo SmithKline Pharmaceuticals LtdComposition :
ofatumumab